1
ALL1
Cleveland ClinicYear
1
ALL1
2020DEALS // DEV.
1
ALL1
DevelopmentsCountry
1
ALL1
U.S.A1
ALL1
InapplicableTherapeutic Area
1
ALL1
Infections and Infectious DiseasesStudy Phase
1
ALL1
UndisclosedDeal Type
1
ALL1
InapplicableProduct Type
1
ALL1
Other Small MoleculeDosage Form
1
ALL1
UndisclosedLead Product
1
ALL1
MelatoninTarget
1
ALL1
Melatonin receptor 1ALead Product(s) : Melatonin,Mercaptopurine
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Undisclosed
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Melatonin? Stem Cells? Researchers Step Up With Unconventional Approaches To COVID-19
Details : Cleveland Clinic compared COVID-19 with the coronavirus that caused the SARS outbreak of 2003 using a technique called “network proximity analysis” to identify combinations of existing drugs.
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
March 16, 2020
Lead Product(s) : Melatonin,Mercaptopurine
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Undisclosed
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable